Natixis Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Sell |
56,362
-3,114
| -5% | -$681K | 0.02% | 607 |
|
|
2025
Q1 | $13.3M | Sell |
59,476
-942
| -2% | -$211K | 0.02% | 567 |
|
|
2024
Q4 | $19.8M | Buy |
60,418
+6,671
| +12% | +$2.19M | 0.04% | 440 |
|
|
2024
Q3 | $16.1M | Buy |
53,747
+4,740
| +10% | +$1.42M | 0.03% | 505 |
|
|
2024
Q2 | $16.1M | Sell |
49,007
-5,904
| -11% | -$1.94M | 0.04% | 455 |
|
|
2024
Q1 | $21.7M | Buy |
54,911
+8,353
| +18% | +$3.31M | 0.05% | 362 |
|
|
2023
Q4 | $16.4M | Sell |
46,558
-3,375
| -7% | -$1.19M | 0.04% | 414 |
|
|
2023
Q3 | $18.7M | Buy |
49,933
+5,954
| +14% | +$2.23M | 0.06% | 331 |
|
|
2023
Q2 | $16.8M | Buy |
43,979
+647
| +1% | +$247K | 0.05% | 377 |
|
|
2023
Q1 | $15M | Buy |
43,332
+3,684
| +9% | +$1.28M | 0.05% | 369 |
|
|
2022
Q4 | $9.33M | Sell |
39,648
-16,098
| -29% | -$3.79M | 0.04% | 502 |
|
|
2022
Q3 | $13.7M | Buy |
55,746
+959
| +2% | +$236K | 0.06% | 355 |
|
|
2022
Q2 | $16.6M | Sell |
54,787
-9,283
| -14% | -$2.81M | 0.07% | 321 |
|
|
2022
Q1 | $26.3M | Buy |
64,070
+2,448
| +4% | +$1.01M | 0.1% | 226 |
|
|
2021
Q4 | $28.9M | Buy |
61,622
+6,513
| +12% | +$3.05M | 0.11% | 204 |
|
|
2021
Q3 | $23.4M | Sell |
55,109
-5,182
| -9% | -$2.2M | 0.1% | 216 |
|
|
2021
Q2 | $21.7M | Buy |
60,291
+3,374
| +6% | +$1.21M | 0.1% | 231 |
|
|
2021
Q1 | $16M | Buy |
56,917
+6,217
| +12% | +$1.75M | 0.08% | 271 |
|
|
2020
Q4 | $14.4M | Buy |
50,700
+2,182
| +4% | +$618K | 0.08% | 270 |
|
|
2020
Q3 | $13.3M | Sell |
48,518
-3,178
| -6% | -$874K | 0.08% | 257 |
|
|
2020
Q2 | $11.7M | Buy |
51,696
+12,820
| +33% | +$2.91M | 0.08% | 278 |
|
|
2020
Q1 | $5.92M | Buy |
38,876
+22,306
| +135% | +$3.4M | 0.05% | 406 |
|
|
2019
Q4 | $2.49M | Buy |
16,570
+1,371
| +9% | +$206K | 0.02% | 750 |
|
|
2019
Q3 | $2.16M | Sell |
15,199
-5,301
| -26% | -$752K | 0.02% | 755 |
|
|
2019
Q2 | $2.57M | Sell |
20,500
-1,375
| -6% | -$172K | 0.02% | 700 |
|
|
2019
Q1 | $2.41M | Buy |
21,875
+11,485
| +111% | +$1.27M | 0.02% | 697 |
|
|
2018
Q4 | $1.02M | Buy |
+10,390
| New | +$1.02M | 0.01% | 904 |
|
|
2018
Q1 | – | Sell |
-12,594
| Closed | -$1.24M | – | 1078 |
|
|
2017
Q4 | $1.24M | Buy |
12,594
+749
| +6% | +$73.9K | 0.01% | 830 |
|
|
2017
Q3 | $1.14M | Buy |
11,845
+1,443
| +14% | +$139K | 0.01% | 847 |
|
|
2017
Q2 | $983K | Sell |
10,402
-148
| -1% | -$14K | 0.01% | 870 |
|
|
2017
Q1 | $861K | Sell |
10,550
-181
| -2% | -$14.8K | 0.01% | 892 |
|
|
2016
Q4 | $910K | Buy |
+10,731
| New | +$910K | 0.01% | 851 |
|
|
2014
Q1 | – | Sell |
-4,835
| Closed | -$237K | – | 1266 |
|
|
2013
Q4 | $237K | Buy |
+4,835
| New | +$237K | ﹤0.01% | 1080 |
|